Nevanac (nepafenac) NDC 82667-500

NDC codes

FDA NDC Directory

Product NDC (as listed)82667-500Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82667-0500Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82667-500-03	82667050003	1 BOTTLE, PLASTIC in 1 CARTON (82667-500-03) / 3 mL in 1 BOTTLE, PLASTICMarketed from Jan 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nevanac
Generic name (nonproprietary): nepafenac
Active ingredients: Nepafenac — 1 mg/mL
Dosage form: Suspension/ drops
Route: Ophthalmic
Labeler: Harrow Eye, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021862
Marketing start: Jan 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 82667-500_42dbdcfd-3edd-46a3-e063-6394a90ac694SPL ID 42dbdcfd-3edd-46a3-e063-6394a90ac694SPL set ID 11b9a0cf-2a70-17ef-e063-6394a90a5d9eRxCUI 578044, 603978UNII 0J9L7J6V8C
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482667050003 followed by a unit qualifier and the quantity

Package 82667-0500-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 5, 2024.

Indications (excerpt from the label)

NEVANAC ® 0.1% is indicated for the treatment of pain and inflammation associated with cataract surgery. NEVANAC is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)